<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:48:59Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:10492960" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:10492960</identifier>
        <datestamp>2023-09-11</datestamp>
        <setSpec>jaha</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" id="jah38711" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="iso-abbrev">J Am Heart Assoc</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)2047-9980</journal-id>
              <journal-id journal-id-type="publisher-id">JAH3</journal-id>
              <journal-id journal-id-type="hwp">ahaoa</journal-id>
              <journal-title-group>
                <journal-title>Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease</journal-title>
              </journal-title-group>
              <issn pub-type="epub">2047-9980</issn>
              <publisher>
                <publisher-name>John Wiley and Sons Inc.</publisher-name>
                <publisher-loc>Hoboken</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC10492960</article-id>
              <article-id pub-id-type="pmcid">PMC10492960</article-id>
              <article-id pub-id-type="pmc-uid">10492960</article-id>
              <article-id pub-id-type="pmid">37581385</article-id>
              <article-id pub-id-type="pmid">37581385</article-id>
              <article-id pub-id-type="doi">10.1161/JAHA.122.029230</article-id>
              <article-id pub-id-type="publisher-id">JAH38711</article-id>
              <article-id pub-id-type="other">JAHA/2022/029230-T</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Original Research</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Original Research</subject>
                  <subj-group subj-group-type="heading">
                    <subject>Epidemiology</subject>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Plasma <styled-content style="fixed-case" toggle="no">Trimethylamine‐<italic toggle="no">N</italic>
</styled-content>‐Oxide and Incident Ischemic Stroke: The Cardiovascular Health Study and the <styled-content style="fixed-case" toggle="no">Multi‐Ethnic</styled-content> Study of Atherosclerosis</article-title>
                <alt-title alt-title-type="right-running-head"><styled-content style="fixed-case" toggle="no">TMAO</styled-content> and Stroke</alt-title>
                <alt-title alt-title-type="left-running-head">Lemaitre et al</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="jah38711-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Lemaitre</surname>
                    <given-names>Rozenn N.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7038-1844</contrib-id>
                  <xref rid="jah38711-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <address>
                    <email>rozenl@uw.edu</email>
                  </address>
                </contrib>
                <contrib id="jah38711-cr-0002" contrib-type="author">
                  <name>
                    <surname>Jensen</surname>
                    <given-names>Paul N.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5836-821X</contrib-id>
                  <xref rid="jah38711-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0003" contrib-type="author">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Zeneng</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6455-8228</contrib-id>
                  <xref rid="jah38711-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0004" contrib-type="author">
                  <name>
                    <surname>Fretts</surname>
                    <given-names>Amanda M.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5358-2345</contrib-id>
                  <xref rid="jah38711-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0005" contrib-type="author">
                  <name>
                    <surname>Sitlani</surname>
                    <given-names>Colleen M.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7656-7482</contrib-id>
                  <xref rid="jah38711-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0006" contrib-type="author">
                  <name>
                    <surname>Nemet</surname>
                    <given-names>Ina</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0657-7121</contrib-id>
                  <xref rid="jah38711-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0007" contrib-type="author">
                  <name>
                    <surname>Sotoodehnia</surname>
                    <given-names>Nona</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-2705-6237</contrib-id>
                  <xref rid="jah38711-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jah38711-aff-0004" ref-type="aff">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0008" contrib-type="author">
                  <name>
                    <surname>de Oliveira Otto</surname>
                    <given-names>Marcia C.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4585-0688</contrib-id>
                  <xref rid="jah38711-aff-0005" ref-type="aff">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0009" contrib-type="author">
                  <name>
                    <surname>Zhu</surname>
                    <given-names>Weifei</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4355-134X</contrib-id>
                  <xref rid="jah38711-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0010" contrib-type="author">
                  <name>
                    <surname>Budoff</surname>
                    <given-names>Matt</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9616-1946</contrib-id>
                  <xref rid="jah38711-aff-0006" ref-type="aff">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0011" contrib-type="author">
                  <name>
                    <surname>Longstreth</surname>
                    <given-names>W. T.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="jah38711-aff-0007" ref-type="aff">
                    <sup>7</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0012" contrib-type="author">
                  <name>
                    <surname>Psaty</surname>
                    <given-names>Bruce M.</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-7278-2190</contrib-id>
                  <xref rid="jah38711-aff-0001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="jah38711-aff-0003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                  <xref rid="jah38711-aff-0008" ref-type="aff">
                    <sup>8</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0013" contrib-type="author">
                  <name>
                    <surname>Siscovick</surname>
                    <given-names>David S.</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0461-175X</contrib-id>
                  <xref rid="jah38711-aff-0009" ref-type="aff">
                    <sup>9</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0014" contrib-type="author">
                  <name>
                    <surname>Hazen</surname>
                    <given-names>Stanley L.</given-names>
                  </name>
                  <degrees>MD, PhD</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7124-6639</contrib-id>
                  <xref rid="jah38711-aff-0002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                  <xref rid="jah38711-aff-0010" ref-type="aff">
                    <sup>10</sup>
                  </xref>
                </contrib>
                <contrib id="jah38711-cr-0015" contrib-type="author">
                  <name>
                    <surname>Mozaffarian</surname>
                    <given-names>Dariush</given-names>
                  </name>
                  <degrees>MD, DrPH</degrees>
                  <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7958-9492</contrib-id>
                  <xref rid="jah38711-aff-0011" ref-type="aff">
                    <sup>11</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="jah38711-aff-0001">
                <label>
                  <sup>1</sup>
                </label>
                <named-content content-type="organisation-division">Cardiovascular Health Research Unit, Department of Medicine</named-content>
                <institution>University of Washington</institution>
                <city>Seattle</city>
                <named-content content-type="country-part">WA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0002">
                <label>
                  <sup>2</sup>
                </label>
                <named-content content-type="organisation-division">Department of Cardiovascular &amp; Metabolic Sciences</named-content>
                <institution>Lerner Research Institute, Cleveland Clinic</institution>
                <city>Cleveland</city>
                <named-content content-type="country-part">OH</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0003">
                <label>
                  <sup>3</sup>
                </label>
                <named-content content-type="organisation-division">Department of Epidemiology</named-content>
                <institution>University of Washington</institution>
                <city>Seattle</city>
                <named-content content-type="country-part">WA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0004">
                <label>
                  <sup>4</sup>
                </label>
                <named-content content-type="organisation-division">Division of Cardiology</named-content>
                <institution>University of Washington</institution>
                <city>Seattle</city>
                <named-content content-type="country-part">WA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0005">
                <label>
                  <sup>5</sup>
                </label>
                <named-content content-type="organisation-division">Division of Epidemiology, Human Genetics and Environmental Science</named-content>
                <institution>The University of Texas Health Science Center at Houston School of Public Health</institution>
                <city>Houston</city>
                <named-content content-type="country-part">TX</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0006">
                <label>
                  <sup>6</sup>
                </label>
                <named-content content-type="organisation-division">Department of Medicine</named-content>
                <institution>University of California at Los Angeles</institution>
                <city>Los Angeles</city>
                <named-content content-type="country-part">CA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0007">
                <label>
                  <sup>7</sup>
                </label>
                <named-content content-type="organisation-division">Department of Neurology</named-content>
                <institution>University of Washington</institution>
                <city>Seattle</city>
                <named-content content-type="country-part">WA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0008">
                <label>
                  <sup>8</sup>
                </label>
                <institution>Kaiser Permanente Washington Health Research Institute</institution>
                <city>Seattle</city>
                <named-content content-type="country-part">WA</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0009">
                <label>
                  <sup>9</sup>
                </label>
                <institution>New York Academy of Medicine</institution>
                <city>New York</city>
                <named-content content-type="country-part">NY</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0010">
                <label>
                  <sup>10</sup>
                </label>
                <named-content content-type="organisation-division">Department of Cardiovascular Medicine, Heart</named-content>
                <institution>Vascular and Thoracic Institute, Cleveland Clinic</institution>
                <city>Cleveland</city>
                <named-content content-type="country-part">OH</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="jah38711-aff-0011">
                <label>
                  <sup>11</sup>
                </label>
                <named-content content-type="organisation-division">Friedman School of Nutrition Science and Policy</named-content>
                <institution>Tufts University</institution>
                <city>Boston</city>
                <named-content content-type="country-part">MA</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label>Correspondence to: Rozenn N. Lemaitre, PhD, University of Washington, Box 359458, 4333 Brooklyn Ave NE, Seattle, WA 98195. Email: <email>rozenl@uw.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>10</day>
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="collection">
                <day>15</day>
                <month>8</month>
                <year>2023</year>
              </pub-date>
              <volume>12</volume>
              <issue seq="170">16</issue>
              <issue-id pub-id-type="doi">10.1002/jah3.v12.16</issue-id>
              <elocation-id>e029230</elocation-id>
              <history>
                <date date-type="received">
                  <day>25</day>
                  <month>1</month>
                  <year>2023</year>
                </date>
                <date date-type="accepted">
                  <day>17</day>
                  <month>7</month>
                  <year>2023</year>
                </date>
              </history>
              <permissions>
                <!--Copyright &#x000a9; 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell-->
                <copyright-statement content-type="article-copyright">© 2023 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="file:JAH3-12-e029230.pdf"/>
              <abstract>
                <sec id="jah38711-sec-0001">
                  <title>Background</title>
                  <p>The association of circulating trimethylamine‐<italic toggle="no">N</italic>‐oxide (TMAO) with stroke has received limited attention. To address this gap, we examined the associations of serial measures of plasma TMAO with incident ischemic stroke.</p>
                </sec>
                <sec id="jah38711-sec-0002">
                  <title>Methods and Results</title>
                  <p>We used a prospective cohort design with data pooled from 2 cohorts. The settings were the CHS (Cardiovascular Health Study), a cohort of older adults, and the MESA (Multi‐Ethnic Study of Atherosclerosis), both in the United States. We measured plasma concentrations of TMAO at baseline and again during the follow‐up using high‐performance liquid chromatography and mass spectrometry. We assessed the association of plasma TMAO with incident ischemic stroke using proportional hazards regression adjusted for risk factors.</p>
                  <p>The combined cohorts included 11 785 participants without a history of stroke, on average 73 (CHS) and 62 (MESA) years old at baseline, including 60% (CHS) and 53% (MESA) women. We identified 1031 total incident ischemic strokes during a median 15‐year follow‐up in the combined cohorts. In multivariable analyses, TMAO was significantly associated with incident ischemic stroke risk (hazard ratios comparing a doubling of TMAO: 1.11 [1.03–1.18], <italic toggle="no">P</italic>=0.004). The association was linear over the range of TMAO concentrations and appeared restricted to those without diagnosed coronary heart disease. An association with hemorrhagic stroke was not found.</p>
                </sec>
                <sec id="jah38711-sec-0003">
                  <title>Conclusions</title>
                  <p>Plasma TMAO levels are associated with incident ischemic stroke in a diverse population.</p>
                </sec>
                <sec id="jah38711-sec-0004">
                  <title>Registration</title>
                  <p>URL: <ext-link xlink:href="https://www.clinicaltrials.gov" ext-link-type="uri">https://www.clinicaltrials.gov</ext-link>. Unique identifier: NCT00005133.</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="jah38711-kwd-0001">epidemiology</kwd>
                <kwd id="jah38711-kwd-0002">risk factors</kwd>
                <kwd id="jah38711-kwd-0003">stroke</kwd>
                <kwd id="jah38711-kwd-0004">TMAO</kwd>
              </kwd-group>
              <kwd-group kwd-group-type="subject-categories">
                <title>Subject Categories</title>
                <kwd>Epidemiology</kwd>
                <kwd>Cardiovascular Disease</kwd>
              </kwd-group>
              <funding-group>
                <award-group id="funding-0001">
                  <funding-source>
                    <institution-wrap>
                      <institution>NIH Office of Dietary Supplements
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000063</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01 HL103866</award-id>
                </award-group>
                <award-group id="funding-0002">
                  <funding-source>National Heart, Lung, and Blood Institute (NHLBI)</funding-source>
                  <award-id>U01HL130114</award-id>
                  <award-id>U01HL080295</award-id>
                  <award-id>75N92021D00006</award-id>
                  <award-id>N01HC85086</award-id>
                  <award-id>N01HC85083</award-id>
                  <award-id>N01HC85082</award-id>
                  <award-id>N01HC85081</award-id>
                  <award-id>N01HC85080</award-id>
                  <award-id>N01HC85079</award-id>
                  <award-id>N01HC55222</award-id>
                  <award-id>HHSN268201800001C</award-id>
                  <award-id>HHSN268200800007C</award-id>
                  <award-id>HHSN268201200036C</award-id>
                </award-group>
                <award-group id="funding-0003">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute of Neurological Disorders and Stroke
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000065</institution-id>
                    </institution-wrap>
                  </funding-source>
                </award-group>
                <award-group id="funding-0004">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Institute on Aging
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000049</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01AG023629</award-id>
                </award-group>
                <award-group id="funding-0005">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Heart, Lung, and Blood Institute
</institution>
                      <institution-id institution-id-type="doi">10.13039/100000050</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>N01‐HC‐95169</award-id>
                  <award-id>N01‐HC‐95168</award-id>
                  <award-id>N01‐HC‐95167</award-id>
                  <award-id>N01‐HC‐95166</award-id>
                  <award-id>N01‐HC‐95165</award-id>
                  <award-id>75N92020D00007</award-id>
                  <award-id>R01 HL127659</award-id>
                  <award-id>N01‐HC‐95164</award-id>
                  <award-id>75N92020D00004</award-id>
                  <award-id>N01‐HC‐95163</award-id>
                  <award-id>75N92020D00006</award-id>
                  <award-id>N01‐HC‐95162</award-id>
                  <award-id>75N92020D00003</award-id>
                  <award-id>N01‐HC‐95161</award-id>
                  <award-id>75N92020D00002</award-id>
                  <award-id>N01‐HC‐95160</award-id>
                  <award-id>75N92020D00005</award-id>
                  <award-id>N01‐HC‐95159</award-id>
                  <award-id>HHSN268201500003I</award-id>
                  <award-id>75N92020D00001</award-id>
                  <award-id>R01HL135920</award-id>
                </award-group>
                <award-group id="funding-0006">
                  <funding-source>
                    <institution-wrap>
                      <institution>National Center for Advancing Translational Sciences
</institution>
                      <institution-id institution-id-type="doi">10.13039/100006108</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>UL1‐TR‐001420</award-id>
                  <award-id>UL1‐TR‐001079</award-id>
                  <award-id>UL1‐TR‐000040</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="3"/>
                <page-count count="9"/>
                <word-count count="5999"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>15 August 2023</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.3 mode:remove_FC converted:21.08.2023</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group id="jah38711-ntgp-0001">
                <fn id="jah38711-note-0001">
                  <p>Supplemental Material is available at <ext-link xlink:href="https://www.ahajournals.org/doi/suppl/10.1161/JAHA.122.029230" ext-link-type="uri">https://www.ahajournals.org/doi/suppl/10.1161/JAHA.122.029230</ext-link>
</p>
                </fn>
                <fn id="jah38711-note-0002">
                  <p>This manuscript was sent to Jose R. Romero, MD, Associate Editor, for review by expert referees, editorial decision, and final disposition.</p>
                </fn>
                <fn id="jah38711-note-0003">
                  <p>For Sources of Funding and Disclosures, see page 8.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body id="jah38711-body-0001">
            <def-list list-content="abbreviations" id="jah38711-lp-0001">
              <title>Nonstandard Abbreviations and Acronyms</title>
              <def-item>
                <term id="jah38711-li-0001">CHS</term>
                <def id="jah38711-li-0003">
                  <p>Cardiovascular Health Study</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38711-li-0004">MESA</term>
                <def id="jah38711-li-0005">
                  <p>Multi‐Ethnic Study of Atherosclerosis</p>
                </def>
              </def-item>
              <def-item>
                <term id="jah38711-li-0006">TMAO</term>
                <def id="jah38711-li-0008">
                  <p>trimethylamine‐<italic toggle="yes">N</italic>‐oxide</p>
                </def>
              </def-item>
            </def-list>
            <p>
              <boxed-text position="anchor" content-type="box" id="jah38711-blkfxd-0001">
                <caption>
                  <title>Clinical Perspective</title>
                </caption>
                <sec id="jah38711-sec-0007">
                  <title>What Is New?</title>
                  <p>
                    <list list-type="bullet" id="jah38711-list-0001">
                      <list-item id="jah38711-li-0009">
                        <p>We report that higher levels of plasma trimethylamine‐<italic toggle="yes">N</italic>‐oxide are associated with a greater risk of incident ischemic stroke in a diverse, population‐based study consisting of 2 large prospective cohorts.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
                <sec id="jah38711-sec-0008">
                  <title>What Are the Clinical Implications?</title>
                  <p>
                    <list list-type="bullet" id="jah38711-list-0002">
                      <list-item id="jah38711-li-0010">
                        <p>In addition to its previously reported association with stroke severity, trimethylamine‐<italic toggle="yes">N</italic>‐oxide may play a role in the development of ischemic stroke.</p>
                      </list-item>
                      <list-item id="jah38711-li-0011">
                        <p>While future studies need to determine whether interventions aimed at lowering circulating trimethylamine‐<italic toggle="yes">N</italic>‐oxide reduce the risk of stroke, it would be prudent to limit known trimethylamine‐<italic toggle="yes">N</italic>‐oxide sources such as red meat consumption.</p>
                      </list-item>
                    </list>
                  </p>
                </sec>
              </boxed-text>
            </p>
            <p>Despite a falling mortality rate in recent years, stroke remains a heavy burden, especially in the elderly.<xref rid="jah38711-bib-0001" ref-type="bibr"><sup>1</sup></xref> Identification of novel modifiable biomarkers associated with stroke risk is of considerable public health importance.</p>
            <p>Plasma trimethylamine‐<italic toggle="yes">N</italic>‐oxide (TMAO) is a biomarker of diet and metabolism, originating from the dietary precursors carnitine, choline, and betaine,<xref rid="jah38711-bib-0002" ref-type="bibr"><sup>2</sup></xref> or directly from fish and shellfish.<xref rid="jah38711-bib-0003" ref-type="bibr"><sup>3</sup></xref> Carnitine, choline, and betaine are converted to trimethylamine by the gut microbiota, and trimethylamine is converted to TMAO postabsorption by the liver flavin monooxygenases.<xref rid="jah38711-bib-0004" ref-type="bibr"><sup>4</sup></xref>, <xref rid="jah38711-bib-0005" ref-type="bibr"><sup>5</sup></xref> Foods rich in TMAO precursors, such as red meat (carnitine, choline) and eggs (choline), as well as seafood increase TMAO levels in dietary interventions.<xref rid="jah38711-bib-0002" ref-type="bibr"><sup>2</sup></xref>, <xref rid="jah38711-bib-0006" ref-type="bibr"><sup>6</sup></xref>, <xref rid="jah38711-bib-0007" ref-type="bibr"><sup>7</sup></xref>
</p>
            <p>In experimental studies, TMAO promotes atherosclerosis and related pathways.<xref rid="jah38711-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="jah38711-bib-0009" ref-type="bibr"><sup>9</sup></xref>, <xref rid="jah38711-bib-0010" ref-type="bibr"><sup>10</sup></xref>, <xref rid="jah38711-bib-0011" ref-type="bibr"><sup>11</sup></xref> In particular, dietary choline or TMAO in mice result in increased plasma TMAO and increased atherosclerotic plaques, and in subjects undergoing coronary angiography, TMAO levels correlate with the extent of vessel disease.<xref rid="jah38711-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="jah38711-bib-0012" ref-type="bibr"><sup>12</sup></xref> TMAO also increases foam cell formation in macrophages and impairs reverse cholesterol transport in mice.<xref rid="jah38711-bib-0013" ref-type="bibr"><sup>13</sup></xref> Therefore we hypothesize that TMAO will be associated with risk of incident ischemic stroke.</p>
            <p>Plasma levels of TMAO are associated with incident atherosclerotic cardiovascular disease<xref rid="jah38711-bib-0014" ref-type="bibr"><sup>14</sup></xref> and all‐cause mortality<xref rid="jah38711-bib-0015" ref-type="bibr"><sup>15</sup></xref> in the CHS (Cardiovascular Health Study), a population‐based cohort study. Similarly, in patients with prevalent risk factors, TMAO is associated with risk of cardiovascular disease and death.<xref rid="jah38711-bib-0016" ref-type="bibr"><sup>16</sup></xref>, <xref rid="jah38711-bib-0017" ref-type="bibr"><sup>17</sup></xref>, <xref rid="jah38711-bib-0018" ref-type="bibr"><sup>18</sup></xref>, <xref rid="jah38711-bib-0019" ref-type="bibr"><sup>19</sup></xref> However, the association of TMAO with incident stroke in population studies has received limited attention. To address this gap, we obtained serial measurements of TMAO in 2 cohort studies, CHS and MESA (Multi‐Ethnic Study of Atherosclerosis), and investigated the association of TMAO with the risk of incident ischemic stroke in the combined sample.</p>
            <sec sec-type="methods" id="jah38711-sec-0009">
              <title>METHODS</title>
              <sec sec-type="data-availability" id="jah38711-sec-0100">
                <title>Data Availability</title>
                <p>The Data and Material Distribution Agreements we signed with CHS and MESA do not allow us to transfer data to outside investigators. Further information on the CHS study can be found at <ext-link xlink:href="https://chs-nhlbi.org/" ext-link-type="uri">https://chs‐nhlbi.org/</ext-link>, and on the MESA study at <ext-link xlink:href="https://www.mesa-nhlbi.org/" ext-link-type="uri">https://www.mesa‐nhlbi.org</ext-link>. Source code for the analysis is in Data <xref rid="jah38711-supitem-0001" ref-type="supplementary-material">S1</xref>.</p>
              </sec>
              <sec id="jah38711-sec-0012">
                <title>Study Design</title>
                <p>We used a prospective cohort design with data pooled from 2 cohorts.</p>
              </sec>
              <sec id="jah38711-sec-0013">
                <title>Study Populations</title>
                <p>The study population consists of participants in 2 prospective cohorts, CHS and MESA. CHS participants were recruited from 4 US communities as previously described.<xref rid="jah38711-bib-0020" ref-type="bibr"><sup>20</sup></xref> The cohort consists of 5201 community‐dwelling men and women, aged ≥65 years at enrollment, recruited in 1989 to 1990, plus an additional 687 predominantly Black participants recruited in 1992 to 1993. All CHS activities are currently approved and participants appropriately consented under the University of Washington Institutional Review Board approval number STUDY00000109. Plasma levels of TMAO were measured in CHS samples collected from 5418 participants at baseline (1989–1990/1992–1993) and again in 1996 to 1997 for participants with a clinic visit at that time. Participants with a history of stroke (n=273) or antibiotic use (n=72) at the time of their first TMAO measurement were excluded from the study, leaving 5073 CHS participants in the analysis. Of those, 2670 participants had 2 TMAO measurements.</p>
                <p>MESA participants were recruited from 6 US communities as previously described.<xref rid="jah38711-bib-0021" ref-type="bibr"><sup>21</sup></xref> The cohort consists of 6814 men and women, aged 45 to 84 years at enrollment and free of clinical cardiovascular disease, who were recruited in 2000 to 2002. The MESA cohort includes 38% White, 28% Black, 22% Hispanic, and 12% Chinese American participants. All MESA activities are currently approved and participants appropriately consented under the University of Washington Institutional Review Board approval numbers STUDY00009029 and STUDY00014523. Plasma levels of TMAO were measured in MESA plasma samples collected at baseline (2000–2002) and again in samples collected during a follow‐up visit (2005–2007). Participants with a history of stroke (n=1), antibiotic use (n=71) at the time of their first TMAO measurement, and those with no follow‐up past their TMAO (n=30) were excluded from the study, leaving 6712 MESA participants in the analysis. Of those, 5265 participants had 2 TMAO measurements.</p>
              </sec>
              <sec id="jah38711-sec-0014">
                <title>Data Collection</title>
                <sec id="jah38711-sec-0015">
                  <title>CHS</title>
                  <p>Information on lifestyle and clinical risk factors was collected at baseline and annual study clinic visits.<xref rid="jah38711-bib-0020" ref-type="bibr"><sup>20</sup></xref> Medication use was assessed by a validated medication inventory.<xref rid="jah38711-bib-0022" ref-type="bibr"><sup>22</sup></xref> Plasma glucose, insulin, lipids, and inflammatory biomarkers were assessed using enzymatic methods.<xref rid="jah38711-bib-0020" ref-type="bibr"><sup>20</sup></xref> Body mass index (BMI) was calculated from body weight (kg) divided by height squared (m<sup>2</sup>). Estimated glomerular filtration rate (eGFR) was calculated with an equation from the Chronic Kidney Disease Epidemiology Collaboration using serum creatinine and cystatin C.<xref rid="jah38711-bib-0023" ref-type="bibr"><sup>23</sup></xref> Physical activity (kcal/wk) was assessed using a modified Minnesota Leisure‐Time Activities questionnaire.<xref rid="jah38711-bib-0024" ref-type="bibr"><sup>24</sup></xref> Diabetes was defined by fasting (≥8 h) plasma glucose ≥126 mg/dL or random (&lt;8 h fasting) glucose ≥200 mg/dL or new use of insulin or oral hypoglycemic medication (assessed annually). Diabetes was also identified using the Centers for Medicare &amp; Medicaid Services records. Diabetes from the Centers for Medicare &amp; Medicaid Services records was defined by at least 2 inpatient (hospital, nursing home, or home health services) or 3 outpatient (outpatient or carrier health services) or ≥1 inpatient and ≥1 outpatient <italic toggle="yes">International Classification of Diseases, Ninth Revision</italic> (<italic toggle="yes">ICD‐9</italic>) claim codes for diabetes diagnosis (with the prefix 250.xx) over a 2‐year period.<xref rid="jah38711-bib-0025" ref-type="bibr"><sup>25</sup></xref>
</p>
                </sec>
                <sec id="jah38711-sec-0016">
                  <title>MESA</title>
                  <p>The design of MESA has been previously described.<xref rid="jah38711-bib-0021" ref-type="bibr"><sup>21</sup></xref> Demographics and lifestyle factors were assessed by interview and questionnaires. Physical activity, metabolic equivalent of task‐minutes/wk, was converted to kcal/wk to harmonize with the CHS physical activity assessment. Blood pressure was the average of the last 2 of 3 measurements using a Dinamap automated blood pressure device. Total cholesterol, high‐density lipoprotein cholesterol, and triglyceride were measured at a central core laboratory. Low‐density lipoprotein cholesterol was calculated using the Friedewald equation. Diabetes was defined as a fasting glucose ≥126 mg/dL, use of diabetes medication or insulin, or self‐report. Medication use, BMI, and eGFR were assessed by the same methods as in CHS.</p>
                </sec>
              </sec>
              <sec id="jah38711-sec-0017">
                <title>Measurement of <styled-content style="fixed-case" toggle="no">TMAO</styled-content>
</title>
                <p>TMAO was measured in EDTA‐plasma samples that were stored at −80 °C. TMAO is stable during long‐term storage at −80 °C and several freeze–thaw cycles.<xref rid="jah38711-bib-0026" ref-type="bibr"><sup>26</sup></xref> TMAO was quantified by stable isotope dilution high‐performance liquid chromatography with online tandem mass spectrometry as previously reported.<xref rid="jah38711-bib-0002" ref-type="bibr"><sup>2</sup></xref> The coefficients of variation of the laboratory assay across the study period varied over batches to a maximum of 5.8%. The same method and laboratory were used to measure TMAO in the 2 cohorts' samples.</p>
              </sec>
              <sec id="jah38711-sec-0018">
                <title>Ascertainment of Stroke</title>
                <sec id="jah38711-sec-0019">
                  <title>CHS</title>
                  <p>Medical records, information from interviews, physician questionnaires, death certificates, medical examiner forms, Health Care Financing Administration hospitalizations, and available computed tomographic or magnetic resonance imaging scans were reviewed by centralized cardiac and stroke adjudication committees to classify events.<xref rid="jah38711-bib-0027" ref-type="bibr"><sup>27</sup></xref>, <xref rid="jah38711-bib-0028" ref-type="bibr"><sup>28</sup></xref> Stroke was defined as a neurological deficit of rapid onset lasting longer than 24 hours unless death supervened or as a subarachnoid hemorrhage. Strokes were classified as ischemic if focal brain deficit without evidence of primary hemorrhage was evident; as hemorrhagic if there was bloody spinal fluid on lumbar puncture or evidence of blood in the subarachnoid space, ventricles, or parenchyma on brain imaging or at surgery or autopsy that did not appear consistent with hemorrhage into an infarction; or as unknown type if information was insufficient for classification. The committee subdivided ischemic stroke into 4 subtypes: small vessel, large vessel, cardioembolic, and other that included mostly uncertain subtypes. Details of the adjudication protocol can be found in Longstreth et al.<xref rid="jah38711-bib-0028" ref-type="bibr"><sup>28</sup></xref>
</p>
                </sec>
                <sec id="jah38711-sec-0020">
                  <title>MESA</title>
                  <p>Stroke events in MESA were ascertained from the MESA baseline to December 2018. Every 9 to 12 months, interim hospitalization was inquired from study participants or their next of kin. Medical records and death certifications were reviewed, and stroke events were adjudicated by a MESA cerebrovascular adjudication committee. The ischemic stroke subtypes were classified as large vessel, extracranial; large vessel, intracranial; cardioembolic; small vessel; other specific mechanisms; multiple mechanisms; or undetermined. A detailed description of the stroke subtype classification and adjudication protocols has been previously reported.<xref rid="jah38711-bib-0029" ref-type="bibr"><sup>29</sup></xref>
</p>
                </sec>
              </sec>
              <sec id="jah38711-sec-0021">
                <title>Statistical Analysis</title>
                <p>In primary analyses, we combined the CHS and MESA data sets with TMAO measures and harmonized covariate adjustments. Cox proportional‐hazards regression was used with the option strata (cohort) to estimate the hazard ratios (HR) and 95% CI for incident ischemic stroke with log2[TMAO concentration]. The time variable in these analyses was time since the first TMAO measurement. Subjects remained at risk until first incident stroke, or in absence of stroke, the earliest of death, loss to follow‐up, or latest date of event ascertainment (June 2015 for CHS and December 2018 for MESA). For participants with 2 TMAO measurements, the value of the first measurement was used as the exposure up until the time of the second measurement, after which time the cumulative average of the 2 measurements was used as the exposure. Adjustment covariates were updated at the time of each TMAO measurement. We fit 3 prespecified models of adjustment. Model 1 (minimally adjusted) included adjustment for age, sex, race or ethnicity, and enrollment site. Model 2 (primary model) additionally adjusted for BMI, waist circumference, smoking status, physical activity, prevalent diabetes, fasting glucose, systolic blood pressure, treated hypertension, low‐density lipoprotein cholesterol, prevalent coronary heart disease (CHD), and prevalent atrial fibrillation. Model 3 included further adjustment for eGFR. The proportional hazards assumption was not violated as assessed with Schoenfeld residuals.<xref rid="jah38711-bib-0030" ref-type="bibr"><sup>30</sup></xref> To test the association of TMAO with ischemic stroke for departure from linearity, we used the Wald test and cubic splines.</p>
                <p>We explored potential effect modification by age (years), sex (binary), evidence of kidney disease based on eGFR &lt;60 mL/min (yes/no), CHD (binary), and BMI (kg/m<sup>2</sup>) in models that included a multiplicative interaction term between TMAO (linear variable) and the effect modifier Model 2 (primary model). Secondary analyses were conducted separately in the 2 cohorts, stratified on race and ethnicity and stratified on the presence or absence of diagnosed CHD.</p>
                <p>Most variables had &lt;5% missing values. Missing covariate data were imputed using demographic and risk variables using single multivariable imputation, which has been shown to produce very similar results as multiple imputation in prior analyses in MESA and CHS.<xref rid="jah38711-bib-0031" ref-type="bibr"><sup>31</sup></xref>
</p>
                <p>The significance level of the primary test was set as 2‐tailed‐alpha = 0.05; and the significance level of interaction tests was set at 0.05/5 (5 effect modifiers) = 0.01. Analyses were performed using Stata version 16.0 (StataCorp, College Station, TX).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="jah38711-sec-0022">
              <title>RESULTS</title>
              <p>The study included 5073 CHS participants and 6712 MESA participants. At baseline, participant mean (SD) age was 73 (6) years in CHS and 62 (10) years in MESA. Women comprised 60% of CHS and 53% of MESA cohorts. In CHS, 15% of participants were Black, while in MESA 28% were Black, 12% were Chinese American, and 22% were Hispanic. Characteristics of the 11 785 combined participants in quartiles of plasma TMAO are shown in Figure <xref rid="jah38711-fig-0001" ref-type="fig">1</xref>. Higher TMAO concentrations were associated with older age, male sex, lower eGFR, and generally unfavorable health profile at baseline. The associations of TMAO with participant characteristics were similar in the different race and ethnic groups (Figure <xref rid="jah38711-supitem-0001" ref-type="supplementary-material">S1</xref>).</p>
              <fig position="float" fig-type="Figure" id="jah38711-fig-0001">
                <label>Figure 1</label>
                <caption>
                  <title>Baseline characteristics of 5073 Cardiovascular Health Study and 6712 Multi‐Ethnic Study of Atherosclerosis participants in each cohort and across quartiles of baseline plasma trimethylamine‐<italic toggle="yes">N</italic>‐oxide levels in the combined 11 785 participants*.</title>
                  <p>*Mean values or % in each cohort, and in the pooled cohorts, trend values across quartiles of trimethylamine‐<italic toggle="yes">N</italic>‐oxide (TMAO) concentration and mean values or % in the first (Q1) and fourth (Q4) quartiles. Positive trends across TMAO quartiles are shown with blue lines, decreasing trends with red lines, and no trend with gray lines, based on univariate tests and threshold <italic toggle="yes">P</italic> value of 0.0015. BMI indicates body mass index; CHD, coronary heart disease; CHF, chronic heart failure; CHS, Cardiovascular Health Study; eGFR, estimated glomerular filtration rate; HDL, high‐density lipoprotein cholesterol; LDL, low‐density lipoprotein cholesterol; MESA, Multi‐Ethnic Study of Atherosclerosis; and TMAO, trimethylamine‐<italic toggle="yes">N</italic>‐oxide.</p>
                </caption>
                <graphic xlink:href="JAH3-12-e029230-g001" position="anchor" id="jats-graphic-1"/>
              </fig>
              <p>Mean and median plasma TMAO concentrations were higher in CHS than MESA, likely due to older age and lower eGFR in CHS (Table <xref rid="jah38711-tbl-0001" ref-type="table">1</xref>). Among the race and ethnic groups, mean TMAO concentrations were highest in White (combined CHS and MESA) and Chinese American participants in MESA. However, adjustment for age and sex reduced the mean concentration in Chinese American participants, while the concentration in White participants remained elevated. Spearman correlations of TMAO at baseline with TMAO concentration in plasma collected 5 to 6 years later were 0.27 in CHS and 0.32 in MESA.</p>
              <table-wrap position="float" id="jah38711-tbl-0001" content-type="Table">
                <label>Table 1</label>
                <caption>
                  <p>Concentration of Plasma Trimethylamine‐<italic toggle="no">N</italic>‐oxide (μmol/L) in the Cardiovascular Health Study, the Multi‐Ethnic Study of Atherosclerosis, the Pooled Cohorts, and by Race or Ethnicity</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <thead>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" rowspan="1" colspan="1"/>
                      <th align="left" rowspan="1" colspan="1">N</th>
                      <th align="left" rowspan="1" colspan="1">Mean (SD)</th>
                      <th align="left" rowspan="1" colspan="1">Median</th>
                      <th align="left" rowspan="1" colspan="1">Min‐Max</th>
                      <th align="left" rowspan="1" colspan="1"/>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td align="left" colspan="6" rowspan="1">Cohort</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">CHS</td>
                      <td align="left" rowspan="1" colspan="1">5073</td>
                      <td align="left" rowspan="1" colspan="1">7.59 (11.15)</td>
                      <td align="left" rowspan="1" colspan="1">4.84</td>
                      <td align="left" rowspan="1" colspan="1">0.01–254.99</td>
                      <td align="left" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">MESA</td>
                      <td align="left" rowspan="1" colspan="1">6712</td>
                      <td align="left" rowspan="1" colspan="1">5.28 (7.17)</td>
                      <td align="left" rowspan="1" colspan="1">3.57</td>
                      <td align="left" rowspan="1" colspan="1">0.31–129.16</td>
                      <td align="left" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pooled cohorts</td>
                      <td align="left" rowspan="1" colspan="1">11 785</td>
                      <td align="left" rowspan="1" colspan="1">6.27 (9.17)</td>
                      <td align="left" rowspan="1" colspan="1">4.07</td>
                      <td align="left" rowspan="1" colspan="1">0.01–254.99</td>
                      <td align="left" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td align="left" colspan="3" rowspan="1">Race or ethnicity</td>
                      <td align="left" rowspan="1" colspan="1"/>
                      <td align="left" rowspan="1" colspan="1"/>
                      <td align="left" rowspan="1" colspan="1">Age‐ and sex‐adjusted means (95% CI)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">White<xref rid="jah38711-note-0005" ref-type="table-fn">*</xref>
</td>
                      <td align="left" rowspan="1" colspan="1">6846</td>
                      <td align="left" rowspan="1" colspan="1">6.88 (9.91)</td>
                      <td align="left" rowspan="1" colspan="1">4.50</td>
                      <td align="left" rowspan="1" colspan="1">0.01–235.63</td>
                      <td align="left" rowspan="1" colspan="1">6.90 (6.67–7.12)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Black<xref rid="jah38711-note-0005" ref-type="table-fn">*</xref>
</td>
                      <td align="left" rowspan="1" colspan="1">2634</td>
                      <td align="left" rowspan="1" colspan="1">5.68 (8.46)</td>
                      <td align="left" rowspan="1" colspan="1">3.75</td>
                      <td align="left" rowspan="1" colspan="1">0.56–254.99</td>
                      <td align="left" rowspan="1" colspan="1">5.65 (5.30–6.01)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Hispanic<xref rid="jah38711-note-0006" ref-type="table-fn">†</xref>
</td>
                      <td align="left" rowspan="1" colspan="1">6613</td>
                      <td align="left" rowspan="1" colspan="1">5.94 (7.96)</td>
                      <td align="left" rowspan="1" colspan="1">3.91</td>
                      <td align="left" rowspan="1" colspan="1">0.01–160.09</td>
                      <td align="left" rowspan="1" colspan="1">5.07 (4.60–5.54)</td>
                    </tr>
                    <tr>
                      <td align="left" style="padding-left:10%" rowspan="1" colspan="1">Chinese American<xref rid="jah38711-note-0006" ref-type="table-fn">†</xref>
</td>
                      <td align="left" rowspan="1" colspan="1">5172</td>
                      <td align="left" rowspan="1" colspan="1">6.70 (10.51)</td>
                      <td align="left" rowspan="1" colspan="1">4.28</td>
                      <td align="left" rowspan="1" colspan="1">0.17–254.99</td>
                      <td align="left" rowspan="1" colspan="1">5.03 (4.39–5.67)</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="jah38711-ntgp-0002">
                  <fn id="jah38711-note-0004">
                    <p>CHS indicates Cardiovascular Health Study; and MESA, Multi‐Ethnic Study of Atherosclerosis.</p>
                  </fn>
                  <fn id="jah38711-note-0005">
                    <label>*</label>
                    <p>Cardiovascular Health Study and Multi‐Ethnic Study of Atherosclerosis.</p>
                  </fn>
                  <fn id="jah38711-note-0006">
                    <label>
                      <sup>†</sup>
                    </label>
                    <p>Multi‐Ethnic Study of Atherosclerosis only.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>We identified 1031 cases of incident ischemic stroke during up to 26 years of follow‐up (median 15.3 years), 741 in CHS and 290 in MESA. Plasma concentrations of TMAO were associated with incident ischemic stroke in the primary analysis (Table <xref rid="jah38711-tbl-0002" ref-type="table">2</xref>; Model 2). After multivariable adjustments, the HR of ischemic stroke associated with a 2‐fold increase in TMAO concentrations was 1.11 (95% CI, 1.03–1.18; <italic toggle="yes">P</italic>=0.004). Further adjustment for eGFR decreased the association (Table <xref rid="jah38711-tbl-0002" ref-type="table">2</xref>; Model 3). Further adjustment for plasma C‐reactive protein, aspirin, statin, and anticoagulant use did not change the study results (Table <xref rid="jah38711-supitem-0001" ref-type="supplementary-material">S1</xref>). Point estimates were similar for the associations of TMAO with cardioembolic (HR, 1.13 [95% CI, 1.00–1.28], <italic toggle="yes">P</italic>=0.06) and noncardioembolic ischemic stroke (HR, 1.10 [95% CI, 1.01–1.19], <italic toggle="yes">P</italic>=0.03). We did not observe departure from linearity for the TMAO‐stroke association (Figure <xref rid="jah38711-supitem-0001" ref-type="supplementary-material">S2</xref>). The overall association was not significantly different by age, sex, BMI, or eGFR (not shown). However, we observed an interaction with baseline CHD (<italic toggle="yes">P</italic> value for interaction: 0.009), such that the association of TMAO with incident ischemic stroke was only observed in participants without baseline CHD (Table <xref rid="jah38711-tbl-0003" ref-type="table">3</xref>).</p>
              <table-wrap position="float" id="jah38711-tbl-0002" content-type="Table">
                <label>Table 2</label>
                <caption>
                  <p>Association of Plasma Trimethylamine‐<italic toggle="no">N</italic>‐Oxide With Incident Ischemic Stroke in the Cardiovascular Health Study, the Multi‐Ethnic Study of Atherosclerosis, and the Pooled Cohorts</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <thead>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1"/>
                      <th align="left" rowspan="1" colspan="1">Model 1</th>
                      <th align="left" rowspan="1" colspan="1">Model 2</th>
                      <th align="left" rowspan="1" colspan="1">Model 3</th>
                    </tr>
                    <tr>
                      <th align="left" colspan="2" rowspan="1">Total N/events</th>
                      <th align="left" colspan="3" rowspan="1">Hazard ratio for a doubling of TMAO (95% CI), <italic toggle="yes">P</italic> value</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">Pooled</td>
                      <td align="left" rowspan="1" colspan="1">11 785/1031</td>
                      <td align="left" rowspan="1" colspan="1">1.15 (1.07–1.23), 5.0×10<sup>−05</sup>
</td>
                      <td align="left" rowspan="1" colspan="1">1.11 (1.03–1.18), 0.004</td>
                      <td align="left" rowspan="1" colspan="1">1.07 (0.99–1.15), 0.07</td>
                    </tr>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">CHS</td>
                      <td align="left" rowspan="1" colspan="1">5073/741</td>
                      <td align="left" rowspan="1" colspan="1">1.13 (1.05–1.22), 0.002</td>
                      <td align="left" rowspan="1" colspan="1">1.09 (1.01–1.18), 0.03</td>
                      <td align="left" rowspan="1" colspan="1">1.05 (0.97–1.14), 0.23</td>
                    </tr>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">MESA</td>
                      <td align="left" rowspan="1" colspan="1">6712/290</td>
                      <td align="left" rowspan="1" colspan="1">1.21 (1.05–1.38), 0.007</td>
                      <td align="left" rowspan="1" colspan="1">1.15 (1.00–1.33), 0.05</td>
                      <td align="left" rowspan="1" colspan="1">1.11 (0.96–1.29), 0.17</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="jah38711-ntgp-0003">
                  <fn id="jah38711-note-0007">
                    <p>Model 1 adjustments: age, sex, race or ethnicity, site. Model 2: Model 1 adjustments + body mass index, waist circumference, smoking, physical activity, prevalent diabetes, fasting glucose, systolic blood pressure, treated hypertension, low‐density lipoprotein, prevalent coronary heart disease, and a history of atrial fibrillation. Model 3: Model 2 adjustments + estimated glomerular filtration rate. CHS indicates Cardiovascular Health Study; MESA, Multi‐Ethnic Study of Atherosclerosis; and TMAO, trimethylamine‐<italic toggle="yes">N</italic>‐oxide.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <table-wrap position="float" id="jah38711-tbl-0003" content-type="Table">
                <label>Table 3</label>
                <caption>
                  <p>Association of Plasma Trimethylamine‐<italic toggle="no">N</italic>‐Oxide With Incident Ischemic Stroke in Those With and Without Baseline Coronary Heart Disease</p>
                </caption>
                <table frame="hsides" rules="groups">
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <col align="left" span="1"/>
                  <thead>
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" colspan="2" style="border-bottom:solid 1px #000000" rowspan="1"/>
                      <th align="left" rowspan="1" colspan="1">Model 2</th>
                      <th align="left" rowspan="1" colspan="1">Model 3</th>
                    </tr>
                    <tr>
                      <th align="left" colspan="2" rowspan="1">Total N/events</th>
                      <th align="left" colspan="2" rowspan="1">Hazard ratio for doubling of TMAO (95% CI), <italic toggle="yes">P</italic> value</th>
                    </tr>
                  </thead>
                  <tbody>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">No CHD<xref rid="jah38711-note-0009" ref-type="table-fn">*</xref>
</td>
                      <td align="left" rowspan="1" colspan="1">10 843/867</td>
                      <td align="left" rowspan="1" colspan="1">1.16 (1.07–1.25), 0.0001</td>
                      <td align="left" rowspan="1" colspan="1">1.13 (1.04–1.22), 0.003</td>
                    </tr>
                    <tr>
                      <td align="left" rowspan="1" colspan="1">With CHD<xref rid="jah38711-note-0010" ref-type="table-fn">†</xref>
</td>
                      <td align="left" rowspan="1" colspan="1">942/164</td>
                      <td align="left" rowspan="1" colspan="1">0.91 (0.77–1.09), 0.32</td>
                      <td align="left" rowspan="1" colspan="1">0.85 (0.71–1.03), 0.10</td>
                    </tr>
                    <tr>
                      <td align="left" colspan="2" rowspan="1"><italic toggle="yes">P</italic> for interaction</td>
                      <td align="left" rowspan="1" colspan="1">0.009</td>
                      <td align="left" rowspan="1" colspan="1">0.008</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot id="jah38711-ntgp-0004">
                  <fn id="jah38711-note-0008">
                    <p>Model 1 adjustments: age, sex, race or ethnicity, site. Model 2: Model 1 adjustments + body mass index, waist circumference, smoking, physical activity, prevalent diabetes, fasting glucose, systolic blood pressure, treated hypertension, low‐density lipoprotein, prevalent coronary heart disease, and a history of atrial fibrillation. Model 3: Model 2 adjustments + estimated glomerular filtration rate. CHD indicates coronary heart disease; and TMAO, trimethylamine‐<italic toggle="yes">N</italic>‐oxide.</p>
                  </fn>
                  <fn id="jah38711-note-0009">
                    <label>*</label>
                    <p>Cardiovascular Health Study and Multi‐Ethnic Study of Atherosclerosis.</p>
                  </fn>
                  <fn id="jah38711-note-0010">
                    <label>
                      <sup>†</sup>
                    </label>
                    <p>Cardiovascular Health Study only.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>We conducted prespecified analyses stratified on the 4 different race or ethnicities to explore whether the TMAO‐stroke association was similar across the race and ethnic groups (Figure <xref rid="jah38711-fig-0002" ref-type="fig">2</xref> and Table <xref rid="jah38711-supitem-0001" ref-type="supplementary-material">S2</xref>). The association of TMAO with ischemic stroke in Hispanic participants appeared to be null; however, the <italic toggle="yes">P</italic> value for interaction of TMAO with race and ethnicity based on 3 degrees of freedom was 0.44.</p>
              <fig position="float" fig-type="Figure" id="jah38711-fig-0002">
                <label>Figure 2</label>
                <caption>
                  <title>Association of plasma trimethylamine‐<italic toggle="yes">N</italic>‐oxide with incident ischemic stroke among participants of different race or ethnicity*.</title>
                  <p>*Hazard ratios of ischemic stroke, 95% CIs, and <italic toggle="yes">P</italic> values for a doubling of trimethylamine‐<italic toggle="yes">N</italic>‐oxide (TMAO) concentrations in models stratified by race and ethnicity and overall. The models were adjusted for age, sex, race, or ethnicity, site, body mass index, waist circumference, smoking, physical activity, prevalent diabetes, fasting glucose, systolic blood pressure, treated hypertension, low‐density lipoprotein cholesterol, prevalent coronary heart disease, and a history of atrial fibrillation. Strokes/N are the number of incident strokes and the total number of participants in each stratum and overall. The <italic toggle="yes">P</italic> value for interaction of TMAO with race and ethnicity based on 3 degrees of freedom was 0.44.</p>
                </caption>
                <graphic xlink:href="JAH3-12-e029230-g002" position="anchor" id="jats-graphic-3"/>
              </fig>
              <p>During follow‐up, 167 hemorrhagic strokes occurred, 110 in CHS and 57 in MESA. In secondary analyses, we observed no association of plasma TMAO with incident hemorrhagic stroke (Table <xref rid="jah38711-supitem-0001" ref-type="supplementary-material">S3</xref>). For example, the HR of hemorrhagic stroke associated with a 2‐fold increase in TMAO concentrations was 0.97 (95% CI, 0.81–1.15; <italic toggle="yes">P</italic>=0.71) with Model 2 multivariate adjustment.</p>
            </sec>
            <sec sec-type="discussion" id="jah38711-sec-0023">
              <title>DISCUSSION</title>
              <p>In this large, prospective study combining 2 community‐based cohorts with diverse populations, we observed a higher risk of incident ischemic stroke associated with elevated plasma TMAO concentrations. The association appeared to be restricted to those without prevalent CHD at the time of TMAO measurement, and in this subgroup, the association was not attenuated by adjustment for eGFR. Evidence of association of TMAO with incident hemorrhagic stroke was not found in the study.</p>
              <p>Prior evidence for an association of TMAO with stroke in population studies is limited. Patients with prevalent stroke reportedly have higher plasma TMAO than healthy controls, and among those with stroke, TMAO is associated with the stroke severity.<xref rid="jah38711-bib-0032" ref-type="bibr"><sup>32</sup></xref>, <xref rid="jah38711-bib-0033" ref-type="bibr"><sup>33</sup></xref>, <xref rid="jah38711-bib-0034" ref-type="bibr"><sup>34</sup></xref> However, the association of TMAO with incident ischemic stroke has received limited attention. In a prospective, case–control study nested in a 5‐year trial, the China Stroke Primary Prevention Trial, increased baseline TMAO levels were associated with higher risks of incident total and ischemic stroke.<xref rid="jah38711-bib-0035" ref-type="bibr"><sup>35</sup></xref> In their multivariable analysis, an increase of 1 log unit of TMAO was associated with an odds ratio of ischemic stroke of 1.22 (1.02–1.46). Median serum TMAO levels were noticeably lower than in our study (2.4 versus 4.1 μmol/L in the pooled CHS and MESA cohorts), suggesting the TMAO‐stroke association might extend to populations with different ranges of TMAO levels. The elevated point estimate (albeit not significant) for the TMAO‐ischemic stroke association in Chinese Americans in our study together with the report from the China Stroke Primary Prevention Trial suggest that further studies on TMAO in Asian populations are warranted.</p>
              <p>A possible mechanism underlying the association of TMAO with ischemic stroke might be an effect of TMAO on atherosclerosis. In mice, dietary supplementation with TMAO has been shown to reduce reverse cholesterol transport, promote foam cell formation, and enhance atherosclerotic lesions.<xref rid="jah38711-bib-0008" ref-type="bibr"><sup>8</sup></xref>, <xref rid="jah38711-bib-0013" ref-type="bibr"><sup>13</sup></xref> Levels of TMAO also correlate with atherosclerotic plaque burden in subjects undergoing coronary angiography<xref rid="jah38711-bib-0008" ref-type="bibr"><sup>8</sup></xref> and with the number of infarcted coronary arteries in patients undergoing surgery,<xref rid="jah38711-bib-0012" ref-type="bibr"><sup>12</sup></xref> although the temporality of these associations cannot be determined. A role of TMAO in atherosclerosis might also underlie reported associations with other incident cardiovascular outcomes in healthy populations. In particular, we previously reported an association of plasma TMAO with the risk of incident atherosclerotic cardiovascular disease, a composite outcome of myocardial infarction, fatal coronary heart disease, stroke, sudden cardiac death, and other atherosclerotic death in CHS.<xref rid="jah38711-bib-0014" ref-type="bibr"><sup>14</sup></xref>
</p>
              <p>The nonsignificant association of TMAO with lower risk of ischemic stroke observed in CHS participants with CHD may be due to chance. Another possibility could be that participants with diagnosed CHD modified their diet (eg, reducing their meat intake), resulting in lower TMAO and biasing the TMAO association with stroke.</p>
              <p>The overall association of TMAO with incident ischemic stroke was diminished by adjustment for eGFR. As also seen in other studies,<xref rid="jah38711-bib-0036" ref-type="bibr"><sup>36</sup></xref> we observed that higher circulating levels of TMAO were correlated with lower eGFR (Spearman <italic toggle="yes">ρ</italic> = −0.37), raising the possibility that kidney function may confound the overall association of TMAO with stroke. However, elevated TMAO itself leads to reduced renal filtration and renal dysfunction in mice, and conversely, reduction in TMAO attenuates renal decline in animal models of chronic kidney disease.<xref rid="jah38711-bib-0036" ref-type="bibr"><sup>36</sup></xref>, <xref rid="jah38711-bib-0037" ref-type="bibr"><sup>37</sup></xref> Therefore, eGFR could also be a mediator of the TMAO‐stroke association. Of note, in the large subgroup of participants without baseline CHD, the association of TMAO with ischemic stroke showed little attenuation with eGFR adjustment; therefore, eGFR is not likely to confound the TMAO‐stroke association in this group.</p>
              <p>Strengths of our study include the prospective design that minimizes reverse causation and selection bias; the repeated measurements strengthen the precision of our exposure measurement and validity of findings; we carefully adjusted for many covariates reducing the impact of residual confounding. CHS and MESA are general, community‐based, prospective cohorts and the study included participants of several races and ethnicities, enhancing the generalizability of the findings. This study also has limitations. As this is an observational study, we cannot conclude on causality. Analyses stratified on race and ethnicity had limited power to detect difference, especially among Chinese American and Hispanic participants who had a relatively small number of incident ischemic strokes. Due to the long follow‐up periods, measurement error may have resulted in an underestimate of the TMAO associations.</p>
              <p>In conclusion, levels of plasma TMAO were associated with incident ischemic stroke in 2 large population‐based prospective cohorts, suggesting that TMAO may play a role in the development of stroke in addition to the previously reported association with stroke severity.</p>
            </sec>
            <sec id="jah38711-sec-0025">
              <title>Sources of Funding</title>
              <p>CHS: this research was supported by R01‐HL135920 from the National Heart, Lung, and Blood Institute (NHLBI) and R01 HL103866 from the NIH Office of Dietary Supplements. These sources funded but did not influence the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The CHS cohort was supported by contracts HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, 75N92021D00006, and grants U01HL080295 and U01HL130114 from the NHLBI, with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided by R01AG023629 from the National Institute on Aging (NIA). MESA: the MESA study was supported by contracts 75N92020D00001, HHSN268201500003I, N01‐HC‐95159, 75N92020D00005, N01‐HC‐95160, 75N92020D00002, N01‐HC‐95161, 75N92020D00003, N01‐HC‐95162, 75N92020D00006, N01‐HC‐95163, 75N92020D00004, N01‐HC‐95164, R01 HL127659, 75N92020D00007, N01‐HC‐95165, N01‐HC‐95166, N01‐HC‐95167, N01‐HC‐95168, and N01‐HC‐95169 from the National Heart, Lung, and Blood Institute, and by grants UL1‐TR‐000040, UL1‐TR‐001079, and UL1‐TR‐001420 from the National Center for Advancing Translational Sciences (NCATS).</p>
            </sec>
            <sec id="jah38711-sec-0026">
              <title>Disclosures</title>
              <p>Dr Psaty serves on the Steering Committee of the Yale Open Data Access project funded by Johnson &amp; Johnson. Dr Mozaffarian reports research funding from the National Institutes of Health, the Gates Foundation, The Rockefeller Foundation, Vail Innovative Global Research, and the Kaiser Permanente Fund at East Bay Community Foundation; personal fees from Acasti Pharma and Barilla; scientific advisory board, Beren Therapeutics, Brightseed, Calibrate, Elysium Health, Filtricine, HumanCo, Instacart, January Inc., Perfect Day, Tiny Organics, and (ended) Day Two, Discern Dx, and Season Health; stock ownership in Calibrate and HumanCo; and chapter royalties from UpToDate. Dr Hazen and Dr Wang report being named as co‐inventors on pending and issued patents held by the Cleveland Clinic relating to cardiovascular diagnostics and therapeutics, and being eligible to receive royalty payments for inventions or discoveries related to cardiovascular diagnostics or therapeutics from Procter &amp; Gamble, Zehna Therapeutics, and Cleveland HeartLab, a wholly owned subsidiary of Quest Diagnostics. Dr Hazen also reports being a paid consultant formerly for Procter &amp; Gamble and currently with Zehna Therapeutics. He also reports having received research funds from Procter &amp; Gamble, Zehna Therapeutics, and Roche Diagnostics. Dr Lemaitre reports research funding from the National Institutes of Health. The remaining authors have no disclosures to report.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="jah38711-supitem-0001" position="float" content-type="local-data">
                <caption>
                  <p>Data S1</p>
                  <p>Tables S1–S3</p>
                  <p>Figures S1–S2</p>
                </caption>
                <media xlink:href="JAH3-12-e029230-s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="jah38711-sec-0024">
              <title>Acknowledgments</title>
              <p>The authors thank the other investigators, the staff, and the participants in the CHS and MESA studies for their valuable contributions. A full list of principal CHS investigators and institutions can be found at <ext-link xlink:href="https://chs-nhlbi.org/" ext-link-type="uri">CHS‐NHLBI.org</ext-link>. A full list of participating MESA investigators and institutions can be found at <ext-link xlink:href="http://www.mesa-nhlbi.org" ext-link-type="uri">http://www.mesa‐nhlbi.org</ext-link>. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
            </ack>
            <ref-list content-type="cited-references" id="jah38711-bibl-0001">
              <title>References</title>
              <ref id="jah38711-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0001"><string-name><surname>Tsao</surname><given-names>CW</given-names></string-name>, <string-name><surname>Aday</surname><given-names>AW</given-names></string-name>, <string-name><surname>Almarzooq</surname><given-names>ZI</given-names></string-name>, <string-name><surname>Alonso</surname><given-names>A</given-names></string-name>, <string-name><surname>Beaton</surname><given-names>AZ</given-names></string-name>, <string-name><surname>Bittencourt</surname><given-names>MS</given-names></string-name>, <string-name><surname>Boehme</surname><given-names>AK</given-names></string-name>, <string-name><surname>Buxton</surname><given-names>AE</given-names></string-name>, <string-name><surname>Carson</surname><given-names>AP</given-names></string-name>, <string-name><surname>Commodore‐Mensah</surname><given-names>Y</given-names></string-name>, et al. <article-title>Heart disease and stroke statistics‐2022 update: a report from the American Heart Association</article-title>. <source>Circulation</source>. <year>2022</year>;<volume>145</volume>:<fpage>e153</fpage>–<lpage>e639</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIR.0000000000001052</pub-id>
<pub-id pub-id-type="pmid">35078371</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0002"><string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Bergeron</surname><given-names>N</given-names></string-name>, <string-name><surname>Levison</surname><given-names>BS</given-names></string-name>, <string-name><surname>Li</surname><given-names>XS</given-names></string-name>, <string-name><surname>Chiu</surname><given-names>S</given-names></string-name>, <string-name><surname>Jia</surname><given-names>X</given-names></string-name>, <string-name><surname>Koeth</surname><given-names>RA</given-names></string-name>, <string-name><surname>Li</surname><given-names>L</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Tang</surname><given-names>WHW</given-names></string-name>, et al. <article-title>Impact of chronic dietary red meat, white meat, or non‐meat protein on trimethylamine N‐oxide metabolism and renal excretion in healthy men and women</article-title>. <source>Eur Heart J</source>. <year>2019</year>;<volume>40</volume>:<fpage>583</fpage>–<lpage>594</lpage>. doi: <pub-id pub-id-type="doi">10.1093/eurheartj/ehy799</pub-id>
<pub-id pub-id-type="pmid">30535398</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0003"><string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Tang</surname><given-names>WHW</given-names></string-name>, <string-name><surname>O'Connell</surname><given-names>T</given-names></string-name>, <string-name><surname>Garcia</surname><given-names>E</given-names></string-name>, <string-name><surname>Jeyarajah</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Li</surname><given-names>XS</given-names></string-name>, <string-name><surname>Jia</surname><given-names>X</given-names></string-name>, <string-name><surname>Weeks</surname><given-names>TL</given-names></string-name>, <string-name><surname>Hazen</surname><given-names>SL</given-names></string-name>. <article-title>Circulating trimethylamine N‐oxide levels following fish or seafood consumption</article-title>. <source>Eur J Nutr</source>. <year>2022</year>;<volume>61</volume>:<fpage>2357</fpage>–<lpage>2364</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00394-022-02803-4</pub-id>
<pub-id pub-id-type="pmid">35113194</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0004"><string-name><surname>Tang</surname><given-names>WH</given-names></string-name>, <string-name><surname>Hazen</surname><given-names>SL</given-names></string-name>. <article-title>The contributory role of gut microbiota in cardiovascular disease</article-title>. <source>J Clin Invest</source>. <year>2014</year>;<volume>124</volume>:<fpage>4204</fpage>–<lpage>4211</lpage>. doi: <pub-id pub-id-type="doi">10.1172/JCI72331</pub-id>
<pub-id pub-id-type="pmid">25271725</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0005"><string-name><surname>Bennett</surname><given-names>BJ</given-names></string-name>, <string-name><surname>de Aguiar Vallim</surname><given-names>TQ</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Shih</surname><given-names>DM</given-names></string-name>, <string-name><surname>Meng</surname><given-names>Y</given-names></string-name>, <string-name><surname>Gregory</surname><given-names>J</given-names></string-name>, <string-name><surname>Allayee</surname><given-names>H</given-names></string-name>, <string-name><surname>Lee</surname><given-names>R</given-names></string-name>, <string-name><surname>Graham</surname><given-names>M</given-names></string-name>, <string-name><surname>Crooke</surname><given-names>R</given-names></string-name>, et al. <article-title>Trimethylamine‐N‐oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation</article-title>. <source>Cell Metab</source>. <year>2013</year>;<volume>17</volume>:<fpage>49</fpage>–<lpage>60</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cmet.2012.12.011</pub-id>
<pub-id pub-id-type="pmid">23312283</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0006"><string-name><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Lai</surname><given-names>HTM</given-names></string-name>, <string-name><surname>de Oliveira Otto</surname><given-names>MC</given-names></string-name>, <string-name><surname>Lemaitre</surname><given-names>RN</given-names></string-name>, <string-name><surname>Fretts</surname><given-names>A</given-names></string-name>, <string-name><surname>Sotoodehnia</surname><given-names>N</given-names></string-name>, <string-name><surname>Budoff</surname><given-names>M</given-names></string-name>, <string-name><surname>DiDonato</surname><given-names>JA</given-names></string-name>, et al. <article-title>Dietary meat, trimethylamine N‐oxide‐related metabolites, and incident cardiovascular disease among older adults: the cardiovascular health study</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2022</year>;<volume>42</volume>:<fpage>e273</fpage>–<lpage>e288</lpage>. doi: <pub-id pub-id-type="doi">10.1161/ATVBAHA.121.316533</pub-id>
<pub-id pub-id-type="pmid">35912635</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0007"><string-name><surname>Miller</surname><given-names>CA</given-names></string-name>, <string-name><surname>Corbin</surname><given-names>KD</given-names></string-name>, <string-name><surname>da Costa</surname><given-names>KA</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>X</given-names></string-name>, <string-name><surname>Galanko</surname><given-names>JA</given-names></string-name>, <string-name><surname>Blevins</surname><given-names>T</given-names></string-name>, <string-name><surname>Bennett</surname><given-names>BJ</given-names></string-name>, <string-name><surname>O'Connor</surname><given-names>A</given-names></string-name>, <string-name><surname>Zeisel</surname><given-names>SH</given-names></string-name>. <article-title>Effect of egg ingestion on trimethylamine‐N‐oxide production in humans: a randomized, controlled, dose‐response study</article-title>. <source>Am J Clin Nutr</source>. <year>2014</year>;<volume>100</volume>:<fpage>778</fpage>–<lpage>786</lpage>. doi: <pub-id pub-id-type="doi">10.3945/ajcn.114.087692</pub-id>
<pub-id pub-id-type="pmid">24944063</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0008"><string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Klipfell</surname><given-names>E</given-names></string-name>, <string-name><surname>Bennett</surname><given-names>BJ</given-names></string-name>, <string-name><surname>Koeth</surname><given-names>R</given-names></string-name>, <string-name><surname>Levison</surname><given-names>BS</given-names></string-name>, <string-name><surname>Dugar</surname><given-names>B</given-names></string-name>, <string-name><surname>Feldstein</surname><given-names>AE</given-names></string-name>, <string-name><surname>Britt</surname><given-names>EB</given-names></string-name>, <string-name><surname>Fu</surname><given-names>X</given-names></string-name>, <string-name><surname>Chung</surname><given-names>YM</given-names></string-name>, et al. <article-title>Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease</article-title>. <source>Nature</source>. <year>2011</year>;<volume>472</volume>:<fpage>57</fpage>–<lpage>63</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature09922</pub-id>
<pub-id pub-id-type="pmid">21475195</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0009"><string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Roberts</surname><given-names>AB</given-names></string-name>, <string-name><surname>Buffa</surname><given-names>JA</given-names></string-name>, <string-name><surname>Levison</surname><given-names>BS</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>W</given-names></string-name>, <string-name><surname>Org</surname><given-names>E</given-names></string-name>, <string-name><surname>Gu</surname><given-names>X</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zamanian‐Daryoush</surname><given-names>M</given-names></string-name>, <string-name><surname>Culley</surname><given-names>MK</given-names></string-name>, et al. <article-title>Non‐lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis</article-title>. <source>Cell</source>. <year>2015</year>;<volume>163</volume>:<fpage>1585</fpage>–<lpage>1595</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2015.11.055</pub-id>
<pub-id pub-id-type="pmid">26687352</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0010"><string-name><surname>Zhu</surname><given-names>W</given-names></string-name>, <string-name><surname>Gregory</surname><given-names>JC</given-names></string-name>, <string-name><surname>Org</surname><given-names>E</given-names></string-name>, <string-name><surname>Buffa</surname><given-names>JA</given-names></string-name>, <string-name><surname>Gupta</surname><given-names>N</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Li</surname><given-names>L</given-names></string-name>, <string-name><surname>Fu</surname><given-names>X</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Mehrabian</surname><given-names>M</given-names></string-name>, et al. <article-title>Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk</article-title>. <source>Cell</source>. <year>2016</year>;<volume>165</volume>:<fpage>111</fpage>–<lpage>124</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2016.02.011</pub-id>
<pub-id pub-id-type="pmid">26972052</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0011"><string-name><surname>Schugar</surname><given-names>RC</given-names></string-name>, <string-name><surname>Shih</surname><given-names>DM</given-names></string-name>, <string-name><surname>Warrier</surname><given-names>M</given-names></string-name>, <string-name><surname>Helsley</surname><given-names>RN</given-names></string-name>, <string-name><surname>Burrows</surname><given-names>A</given-names></string-name>, <string-name><surname>Ferguson</surname><given-names>D</given-names></string-name>, <string-name><surname>Brown</surname><given-names>AL</given-names></string-name>, <string-name><surname>Gromovsky</surname><given-names>AD</given-names></string-name>, <string-name><surname>Heine</surname><given-names>M</given-names></string-name>, <string-name><surname>Chatterjee</surname><given-names>A</given-names></string-name>, et al. <article-title>The TMAO‐producing enzyme flavin‐containing monooxygenase 3 regulates obesity and the beiging of white adipose tissue</article-title>. <source>Cell Rep</source>. <year>2017</year>;<volume>20</volume>:<fpage>279</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2017.06.053</pub-id><pub-id pub-id-type="pmid">28683320</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0012"><string-name><surname>Mafune</surname><given-names>A</given-names></string-name>, <string-name><surname>Iwamoto</surname><given-names>T</given-names></string-name>, <string-name><surname>Tsutsumi</surname><given-names>Y</given-names></string-name>, <string-name><surname>Nakashima</surname><given-names>A</given-names></string-name>, <string-name><surname>Yamamoto</surname><given-names>I</given-names></string-name>, <string-name><surname>Yokoyama</surname><given-names>K</given-names></string-name>, <string-name><surname>Yokoo</surname><given-names>T</given-names></string-name>, <string-name><surname>Urashima</surname><given-names>M</given-names></string-name>. <article-title>Associations among serum trimethylamine‐N‐oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross‐sectional study</article-title>. <source>Clin Exp Nephrol</source>. <year>2016</year>;<volume>20</volume>:<fpage>731</fpage>–<lpage>739</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10157-015-1207-y</pub-id>
<pub-id pub-id-type="pmid">26676906</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0013"><string-name><surname>Koeth</surname><given-names>RA</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Levison</surname><given-names>BS</given-names></string-name>, <string-name><surname>Buffa</surname><given-names>JA</given-names></string-name>, <string-name><surname>Org</surname><given-names>E</given-names></string-name>, <string-name><surname>Sheehy</surname><given-names>BT</given-names></string-name>, <string-name><surname>Britt</surname><given-names>EB</given-names></string-name>, <string-name><surname>Fu</surname><given-names>X</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Li</surname><given-names>L</given-names></string-name>, et al. <article-title>Intestinal microbiota metabolism of L‐carnitine, a nutrient in red meat, promotes atherosclerosis</article-title>. <source>Nat Med</source>. <year>2013</year>;<volume>19</volume>:<fpage>576</fpage>–<lpage>585</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nm.3145</pub-id>
<pub-id pub-id-type="pmid">23563705</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0014"><string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Nemet</surname><given-names>I</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Lai</surname><given-names>HTM</given-names></string-name>, <string-name><surname>de Oliveira Otto</surname><given-names>MC</given-names></string-name>, <string-name><surname>Lemaitre</surname><given-names>RN</given-names></string-name>, <string-name><surname>Fretts</surname><given-names>AM</given-names></string-name>, <string-name><surname>Sotoodehnia</surname><given-names>N</given-names></string-name>, <string-name><surname>Budoff</surname><given-names>M</given-names></string-name>, <string-name><surname>DiDonato</surname><given-names>JA</given-names></string-name>, et al. <article-title>Longitudinal plasma measures of trimethylamine N‐oxide and risk of atherosclerotic cardiovascular disease events in community‐based older adults</article-title>. <source>J Am Heart Assoc</source>. <year>2021</year>;<volume>10</volume>:<elocation-id>e020646</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.120.020646</pub-id><pub-id pub-id-type="pmid">34398665</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0015"><string-name><surname>Fretts</surname><given-names>AM</given-names></string-name>, <string-name><surname>Hazen</surname><given-names>SL</given-names></string-name>, <string-name><surname>Jensen</surname><given-names>P</given-names></string-name>, <string-name><surname>Budoff</surname><given-names>M</given-names></string-name>, <string-name><surname>Sitlani</surname><given-names>CM</given-names></string-name>, <string-name><surname>Wang</surname><given-names>M</given-names></string-name>, <string-name><surname>de Oliveira Otto</surname><given-names>MC</given-names></string-name>, <string-name><surname>DiDonato</surname><given-names>JA</given-names></string-name>, <string-name><surname>Lee</surname><given-names>Y</given-names></string-name>, <string-name><surname>Psaty</surname><given-names>BM</given-names></string-name>, et al. <article-title>Association of trimethylamine N‐oxide and metabolites with mortality in older adults</article-title>. <source>JAMA Netw Open</source>. <year>2022</year>;<volume>5</volume>:<elocation-id>e2213242</elocation-id>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.13242</pub-id><pub-id pub-id-type="pmid">35594043</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0016"><string-name><surname>Tang</surname><given-names>WH</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Levison</surname><given-names>BS</given-names></string-name>, <string-name><surname>Koeth</surname><given-names>RA</given-names></string-name>, <string-name><surname>Britt</surname><given-names>EB</given-names></string-name>, <string-name><surname>Fu</surname><given-names>X</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Hazen</surname><given-names>SL</given-names></string-name>. <article-title>Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk</article-title>. <source>N Engl J Med</source>. <year>2013</year>;<volume>368</volume>:<fpage>1575</fpage>–<lpage>1584</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1109400</pub-id>
<pub-id pub-id-type="pmid">23614584</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0017"><string-name><surname>Schiattarella</surname><given-names>GG</given-names></string-name>, <string-name><surname>Sannino</surname><given-names>A</given-names></string-name>, <string-name><surname>Toscano</surname><given-names>E</given-names></string-name>, <string-name><surname>Giugliano</surname><given-names>G</given-names></string-name>, <string-name><surname>Gargiulo</surname><given-names>G</given-names></string-name>, <string-name><surname>Franzone</surname><given-names>A</given-names></string-name>, <string-name><surname>Trimarco</surname><given-names>B</given-names></string-name>, <string-name><surname>Esposito</surname><given-names>G</given-names></string-name>, <string-name><surname>Perrino</surname><given-names>C</given-names></string-name>. <article-title>Gut microbe‐generated metabolite trimethylamine‐N‐oxide as cardiovascular risk biomarker: a systematic review and dose‐response meta‐analysis</article-title>. <source>Eur Heart J</source>. <year>2017</year>;<volume>38</volume>:<fpage>2948</fpage>–<lpage>2956</lpage>. doi: <pub-id pub-id-type="doi">10.1093/eurheartj/ehx342</pub-id>
<pub-id pub-id-type="pmid">29020409</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0018"><string-name><surname>Qi</surname><given-names>J</given-names></string-name>, <string-name><surname>You</surname><given-names>T</given-names></string-name>, <string-name><surname>Li</surname><given-names>J</given-names></string-name>, <string-name><surname>Pan</surname><given-names>T</given-names></string-name>, <string-name><surname>Xiang</surname><given-names>L</given-names></string-name>, <string-name><surname>Han</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>L</given-names></string-name>. <article-title>Circulating trimethylamine N‐oxide and the risk of cardiovascular diseases: a systematic review and meta‐analysis of 11 prospective cohort studies</article-title>. <source>J Cell Mol Med</source>. <year>2018</year>;<volume>22</volume>:<fpage>185</fpage>–<lpage>194</lpage>. doi: <pub-id pub-id-type="doi">10.1111/jcmm.13307</pub-id>
<pub-id pub-id-type="pmid">28782886</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0019"><string-name><surname>Heianza</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ma</surname><given-names>W</given-names></string-name>, <string-name><surname>Manson</surname><given-names>JE</given-names></string-name>, <string-name><surname>Rexrode</surname><given-names>KM</given-names></string-name>, <string-name><surname>Qi</surname><given-names>L</given-names></string-name>. <article-title>Gut microbiota metabolites and risk of major adverse cardiovascular disease events and death: a systematic review and meta‐analysis of prospective studies</article-title>. <source>J Am Heart Assoc</source>. <year>2017</year>;<volume>6</volume>:<elocation-id>e004947</elocation-id>. doi: <pub-id pub-id-type="doi">10.1161/JAHA.116.004947</pub-id><pub-id pub-id-type="pmid">28663251</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0020"><string-name><surname>Fried</surname><given-names>LP</given-names></string-name>, <string-name><surname>Borhani</surname><given-names>NO</given-names></string-name>, <string-name><surname>Enright</surname><given-names>P</given-names></string-name>, <string-name><surname>Furberg</surname><given-names>CD</given-names></string-name>, <string-name><surname>Gardin</surname><given-names>JM</given-names></string-name>, <string-name><surname>Kronmal</surname><given-names>RA</given-names></string-name>, <string-name><surname>Kuller</surname><given-names>LH</given-names></string-name>, <string-name><surname>Manolio</surname><given-names>TA</given-names></string-name>, <string-name><surname>Mittelmark</surname><given-names>MB</given-names></string-name>, <string-name><surname>Newman</surname><given-names>A</given-names></string-name>, et al. <article-title>The cardiovascular health study: design and rationale</article-title>. <source>Ann Epidemiol</source>. <year>1991</year>;<volume>1</volume>:<fpage>263</fpage>–<lpage>276</lpage>. doi: <pub-id pub-id-type="doi">10.1016/1047-2797(91)90005-W</pub-id>
<pub-id pub-id-type="pmid">1669507</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0021"><string-name><surname>Bild</surname><given-names>DE</given-names></string-name>, <string-name><surname>Bluemke</surname><given-names>DA</given-names></string-name>, <string-name><surname>Burke</surname><given-names>GL</given-names></string-name>, <string-name><surname>Detrano</surname><given-names>R</given-names></string-name>, <string-name><surname>Diez Roux</surname><given-names>AV</given-names></string-name>, <string-name><surname>Folsom</surname><given-names>AR</given-names></string-name>, <string-name><surname>Greenland</surname><given-names>P</given-names></string-name>, <string-name><surname>Jacob</surname><given-names>DR</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Kronmal</surname><given-names>R</given-names></string-name>, <string-name><surname>Liu</surname><given-names>K</given-names></string-name>, et al. <article-title>Multi‐Ethnic Study of Atherosclerosis: objectives and design</article-title>. <source>Am J Epidemiol</source>. <year>2002</year>;<volume>156</volume>:<fpage>871</fpage>–<lpage>881</lpage>. doi: <pub-id pub-id-type="doi">10.1093/aje/kwf113</pub-id>
<pub-id pub-id-type="pmid">12397006</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0022"><string-name><surname>Psaty</surname><given-names>BM</given-names></string-name>, <string-name><surname>Lee</surname><given-names>M</given-names></string-name>, <string-name><surname>Savage</surname><given-names>PJ</given-names></string-name>, <string-name><surname>Rutan</surname><given-names>GH</given-names></string-name>, <string-name><surname>German</surname><given-names>PS</given-names></string-name>, <string-name><surname>Lyles</surname><given-names>M</given-names></string-name>. <article-title>Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group</article-title>. <source>J Clin Epidemiol</source>. <year>1992</year>;<volume>45</volume>:<fpage>683</fpage>–<lpage>692</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0895-4356(92)90143-B</pub-id>
<pub-id pub-id-type="pmid">1607909</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0023"><string-name><surname>Inker</surname><given-names>LA</given-names></string-name>, <string-name><surname>Schmid</surname><given-names>CH</given-names></string-name>, <string-name><surname>Tighiouart</surname><given-names>H</given-names></string-name>, <string-name><surname>Eckfeldt</surname><given-names>JH</given-names></string-name>, <string-name><surname>Feldman</surname><given-names>HI</given-names></string-name>, <string-name><surname>Greene</surname><given-names>T</given-names></string-name>, <string-name><surname>Kusek</surname><given-names>JW</given-names></string-name>, <string-name><surname>Manzi</surname><given-names>J</given-names></string-name>, <string-name><surname>Van Lente</surname><given-names>F</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>YL</given-names></string-name>, et al. <article-title>Estimating glomerular filtration rate from serum creatinine and cystatin C</article-title>. <source>N Engl J Med</source>. <year>2012</year>;<volume>367</volume>:<fpage>20</fpage>–<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1056/NEJMoa1114248</pub-id>
<pub-id pub-id-type="pmid">22762315</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0024"><string-name><surname>Taylor</surname><given-names>HL</given-names></string-name>, <string-name><surname>Jacobs</surname><given-names>DR</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Schucker</surname><given-names>B</given-names></string-name>, <string-name><surname>Knudsen</surname><given-names>J</given-names></string-name>, <string-name><surname>Leon</surname><given-names>AS</given-names></string-name>, <string-name><surname>Debacker</surname><given-names>G</given-names></string-name>. <article-title>A questionnaire for the assessment of leisure time physical activities</article-title>. <source>J Chronic Dis</source>. <year>1978</year>;<volume>31</volume>:<fpage>741</fpage>–<lpage>755</lpage>. doi: <pub-id pub-id-type="doi">10.1016/0021-9681(78)90058-9</pub-id>
<pub-id pub-id-type="pmid">748370</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0025"><string-name><surname>Brutsaert</surname><given-names>EF</given-names></string-name>, <string-name><surname>Biggs</surname><given-names>ML</given-names></string-name>, <string-name><surname>Delaney</surname><given-names>JA</given-names></string-name>, <string-name><surname>Djousse</surname><given-names>L</given-names></string-name>, <string-name><surname>Gottdiener</surname><given-names>JS</given-names></string-name>, <string-name><surname>Ix</surname><given-names>JH</given-names></string-name>, <string-name><surname>Kim</surname><given-names>F</given-names></string-name>, <string-name><surname>Mukamal</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Siscovick</surname><given-names>DS</given-names></string-name>, <string-name><surname>Tracy</surname><given-names>RP</given-names></string-name>, et al. <article-title>Longitudinal assessment of N‐terminal pro‐B‐type natriuretic peptide and risk of diabetes in older adults: the cardiovascular health study</article-title>. <source>Metabolism</source>. <year>2016</year>;<volume>65</volume>:<fpage>1489</fpage>–<lpage>1497</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.metabol.2016.06.002</pub-id>
<pub-id pub-id-type="pmid">27621184</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0026"><string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Levison</surname><given-names>BS</given-names></string-name>, <string-name><surname>Hazen</surname><given-names>JE</given-names></string-name>, <string-name><surname>Donahue</surname><given-names>L</given-names></string-name>, <string-name><surname>Li</surname><given-names>XM</given-names></string-name>, <string-name><surname>Hazen</surname><given-names>SL</given-names></string-name>. <article-title>Measurement of trimethylamine‐N‐oxide by stable isotope dilution liquid chromatography tandem mass spectrometry</article-title>. <source>Anal Biochem</source>. <year>2014</year>;<volume>455</volume>:<fpage>35</fpage>–<lpage>40</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ab.2014.03.016</pub-id>
<pub-id pub-id-type="pmid">24704102</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0027"><string-name><surname>Ives</surname><given-names>DG</given-names></string-name>, <string-name><surname>Fitzpatrick</surname><given-names>AL</given-names></string-name>, <string-name><surname>Bild</surname><given-names>DE</given-names></string-name>, <string-name><surname>Psaty</surname><given-names>BM</given-names></string-name>, <string-name><surname>Kuller</surname><given-names>LH</given-names></string-name>, <string-name><surname>Crowley</surname><given-names>PM</given-names></string-name>, <string-name><surname>Cruise</surname><given-names>RG</given-names></string-name>, <string-name><surname>Theroux</surname><given-names>S</given-names></string-name>. <article-title>Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study</article-title>. <source>Ann Epidemiol</source>. <year>1995</year>;<volume>5</volume>:<fpage>278</fpage>–<lpage>285</lpage>. doi: <pub-id pub-id-type="doi">10.1016/1047-2797(94)00093-9</pub-id>
<pub-id pub-id-type="pmid">8520709</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0028"><string-name><surname>Longstreth</surname><given-names>WT</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Bernick</surname><given-names>C</given-names></string-name>, <string-name><surname>Fitzpatrick</surname><given-names>A</given-names></string-name>, <string-name><surname>Cushman</surname><given-names>M</given-names></string-name>, <string-name><surname>Knepper</surname><given-names>L</given-names></string-name>, <string-name><surname>Lima</surname><given-names>J</given-names></string-name>, <string-name><surname>Furberg</surname><given-names>CD</given-names></string-name>. <article-title>Frequency and predictors of stroke death in 5888 participants in the Cardiovascular Health Study</article-title>. <source>Neurology</source>. <year>2001</year>;<volume>56</volume>:<fpage>368</fpage>–<lpage>375</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.56.3.368</pub-id>
<pub-id pub-id-type="pmid">11171903</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0029"><string-name><surname>Longstreth</surname><given-names>WT</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Gasca</surname><given-names>NC</given-names></string-name>, <string-name><surname>Gottesman</surname><given-names>RF</given-names></string-name>, <string-name><surname>Pearce</surname><given-names>JB</given-names></string-name>, <string-name><surname>Sacco</surname><given-names>RL</given-names></string-name>. <article-title>Adjudication of transient ischemic attack and stroke in the Multi‐Ethnic Study of Atherosclerosis</article-title>. <source>Neuroepidemiology</source>. <year>2018</year>;<volume>50</volume>:<fpage>23</fpage>–<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1159/000486174</pub-id>
<pub-id pub-id-type="pmid">29324452</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0030"><string-name><surname>Grambsch</surname><given-names>P</given-names></string-name>, <string-name><surname>Therneau</surname><given-names>T</given-names></string-name>. <article-title>Proportional hazards tests and diagnostics based on weighted residuals</article-title>. <source>Biometrika</source>. <year>1994</year>;<volume>81</volume>:<fpage>515</fpage>–<lpage>526</lpage>. doi: <pub-id pub-id-type="doi">10.1093/biomet/81.3.515</pub-id>
</mixed-citation>
              </ref>
              <ref id="jah38711-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0031"><string-name><surname>Arnold</surname><given-names>AM</given-names></string-name>, <string-name><surname>Kronmal</surname><given-names>RA</given-names></string-name>. <article-title>Multiple imputation of baseline data in the cardiovascular health study</article-title>. <source>Am J Epidemiol</source>. <year>2003</year>;<volume>157</volume>:<fpage>74</fpage>–<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1093/aje/kwf156</pub-id>
<pub-id pub-id-type="pmid">12505893</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0032"><string-name><surname>Rexidamu</surname><given-names>M</given-names></string-name>, <string-name><surname>Li</surname><given-names>H</given-names></string-name>, <string-name><surname>Jin</surname><given-names>H</given-names></string-name>, <string-name><surname>Huang</surname><given-names>J</given-names></string-name>. <article-title>Serum levels of trimethylamine‐N‐oxide in patients with ischemic stroke</article-title>. <source>Biosci Rep</source>. <year>2019</year>;<volume>39</volume>:<elocation-id>BSR20190515</elocation-id>. doi: <pub-id pub-id-type="doi">10.1042/BSR20190515</pub-id><pub-id pub-id-type="pmid">31142624</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0033"><string-name><surname>Wu</surname><given-names>C</given-names></string-name>, <string-name><surname>Xue</surname><given-names>F</given-names></string-name>, <string-name><surname>Lian</surname><given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name><surname>Wu</surname><given-names>D</given-names></string-name>, <string-name><surname>Xie</surname><given-names>N</given-names></string-name>, <string-name><surname>Chang</surname><given-names>W</given-names></string-name>, <string-name><surname>Chen</surname><given-names>F</given-names></string-name>, <string-name><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name><surname>Wei</surname><given-names>W</given-names></string-name>, et al. <article-title>Relationship between elevated plasma trimethylamine N‐oxide levels and increased stroke injury</article-title>. <source>Neurology</source>. <year>2020</year>;<volume>94</volume>:<fpage>e667</fpage>–<lpage>e677</lpage>. doi: <pub-id pub-id-type="doi">10.1212/WNL.0000000000008862</pub-id>
<pub-id pub-id-type="pmid">31907287</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0034"><string-name><surname>Zhu</surname><given-names>W</given-names></string-name>, <string-name><surname>Romano</surname><given-names>KA</given-names></string-name>, <string-name><surname>Li</surname><given-names>L</given-names></string-name>, <string-name><surname>Buffa</surname><given-names>JA</given-names></string-name>, <string-name><surname>Sangwan</surname><given-names>N</given-names></string-name>, <string-name><surname>Prakash</surname><given-names>P</given-names></string-name>, <string-name><surname>Tittle</surname><given-names>AN</given-names></string-name>, <string-name><surname>Li</surname><given-names>XS</given-names></string-name>, <string-name><surname>Fu</surname><given-names>X</given-names></string-name>, <string-name><surname>Androjna</surname><given-names>C</given-names></string-name>, et al. <article-title>Gut microbes impact stroke severity via the trimethylamine N‐oxide pathway</article-title>. <source>Cell Host Microbe</source>. <year>2021</year>;<volume>29</volume>:<fpage>1199</fpage>–<lpage>1208.e5</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.chom.2021.05.002</pub-id>
<pub-id pub-id-type="pmid">34139173</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0035"><string-name><surname>Nie</surname><given-names>J</given-names></string-name>, <string-name><surname>Xie</surname><given-names>L</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>BX</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y</given-names></string-name>, <string-name><surname>Qiu</surname><given-names>B</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>F</given-names></string-name>, <string-name><surname>Li</surname><given-names>GF</given-names></string-name>, <string-name><surname>He</surname><given-names>M</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname><given-names>B</given-names></string-name>, et al. <article-title>Serum trimethylamine N‐oxide concentration is positively associated with first stroke in hypertensive patients</article-title>. <source>Stroke</source>. <year>2018</year>;<volume>49</volume>:<fpage>2021</fpage>–<lpage>2028</lpage>. doi: <pub-id pub-id-type="doi">10.1161/STROKEAHA.118.021997</pub-id>
<pub-id pub-id-type="pmid">30354996</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0036"><string-name><surname>Tang</surname><given-names>WH</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z</given-names></string-name>, <string-name><surname>Kennedy</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Buffa</surname><given-names>JA</given-names></string-name>, <string-name><surname>Agatisa‐Boyle</surname><given-names>B</given-names></string-name>, <string-name><surname>Li</surname><given-names>XS</given-names></string-name>, <string-name><surname>Levison</surname><given-names>BS</given-names></string-name>, <string-name><surname>Hazen</surname><given-names>SL</given-names></string-name>. <article-title>Gut microbiota‐dependent trimethylamine N‐oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease</article-title>. <source>Circ Res</source>. <year>2015</year>;<volume>116</volume>:<fpage>448</fpage>–<lpage>455</lpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.305360</pub-id>
<pub-id pub-id-type="pmid">25599331</pub-id></mixed-citation>
              </ref>
              <ref id="jah38711-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="jah38711-cit-0037"><string-name><surname>Gupta</surname><given-names>N</given-names></string-name>, <string-name><surname>Buffa</surname><given-names>JA</given-names></string-name>, <string-name><surname>Roberts</surname><given-names>AB</given-names></string-name>, <string-name><surname>Sangwan</surname><given-names>N</given-names></string-name>, <string-name><surname>Skye</surname><given-names>SM</given-names></string-name>, <string-name><surname>Li</surname><given-names>L</given-names></string-name>, <string-name><surname>Ho</surname><given-names>KJ</given-names></string-name>, <string-name><surname>Varga</surname><given-names>J</given-names></string-name>, <string-name><surname>DiDonato</surname><given-names>JA</given-names></string-name>, <string-name><surname>Tang</surname><given-names>WHW</given-names></string-name>, et al. <article-title>Targeted inhibition of gut microbial trimethylamine N‐oxide production reduces renal tubulointerstitial fibrosis and functional impairment in a murine model of chronic kidney disease</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2020</year>;<volume>40</volume>:<fpage>1239</fpage>–<lpage>1255</lpage>. doi: <pub-id pub-id-type="doi">10.1161/ATVBAHA.120.314139</pub-id>
<pub-id pub-id-type="pmid">32212854</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
